Login / Signup

Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukaemia and the occurrence of depressive symptoms.

Katarzyna Gibek
Published in: Contemporary oncology (Poznan, Poland) (2024)
The results indicate the influence of the occurrence of TKI treatment side effects on the development of depressive symptoms. Patients' quality of life can be improved with the cooperation of medical staff in reducing/alleviating the side effects.
Keyphrases
  • depressive symptoms
  • risk assessment
  • healthcare
  • end stage renal disease
  • social support
  • ejection fraction
  • bone marrow
  • dendritic cells
  • immune response
  • physical activity